EU Heart Condition Warning For COVID-19 Vaccines Comirnaty And Spikevax

Capillary Leak Syndrome A Side-Effect Of Janssen Vaccine

All four coronavirus vaccines authorized for marketing in the EU/European Economic Area have had their safety information updated because of various adverse events including myocarditis, pericarditis and capillary leak syndrome.

Close-up view of searching information about COVID vaccine side effects
The EMA is keeping a close eye on COVID-19 vaccine safety signals • Source: Alamy

Myocarditis and pericarditis should be listed as new side-effects of two COVID-19 vaccines, Pfizer Inc./BioNTech SE’s Comirnaty and Moderna, Inc.’s Spikevax, says the European Medicines Agency’s drug safety committee, the PRAC.

The recommendation came after the PRAC conducted an in-depth review of available evidence, including 145 cases of myocarditis reported in...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography